Mucositis News and Research

RSS
Findings on the use of Traumeel S in children with mucositis undergoing SCT presented

Findings on the use of Traumeel S in children with mucositis undergoing SCT presented

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Updated data on XL184 study in patients with glioblastoma multiforme presented

Updated data on XL184 study in patients with glioblastoma multiforme presented

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

Access Pharmaceuticals' update on its European commercial launch of Mugard

Access Pharmaceuticals' update on its European commercial launch of Mugard

Phase I clinical trial results for Fentanyl Lauriad announced by BioAlliance Pharma

Phase I clinical trial results for Fentanyl Lauriad announced by BioAlliance Pharma

iMedicor to market Access Pharmaceuticals' MuGard in North America

iMedicor to market Access Pharmaceuticals' MuGard in North America

Phase 2 trial results of Bayer's Nexavar in combination with capecitabine announced

Phase 2 trial results of Bayer's Nexavar in combination with capecitabine announced

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Avaxia Biologics receives NIH grant to develop an antibody therapeutic for oral mucositis

Avaxia Biologics receives NIH grant to develop an antibody therapeutic for oral mucositis

Accupac to manufacture Access Pharmaceuticals' MuGard

Accupac to manufacture Access Pharmaceuticals' MuGard

GI Company's Phase II study demonstrates safety of rhITF oral spray formulation

GI Company's Phase II study demonstrates safety of rhITF oral spray formulation

Bayer announces new data on novel anti-cancer compound

Bayer announces new data on novel anti-cancer compound

CAPHOSOL shown to benefit cancer patients undergoing chemotherapy and radiation therapy

CAPHOSOL shown to benefit cancer patients undergoing chemotherapy and radiation therapy

Sunesis Pharmaceuticals presents data of Voreloxin in patients with acute myeloid leukemia and ovarian cancer

Sunesis Pharmaceuticals presents data of Voreloxin in patients with acute myeloid leukemia and ovarian cancer

Anadis Ltd's clinical trial against mucositis approved in Israel

Anadis Ltd's clinical trial against mucositis approved in Israel

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

Report says cancer clinicians should understand and consider the economic impact of new interventions

Report says cancer clinicians should understand and consider the economic impact of new interventions